Alpha 1-Antitrypsin Deficiency - 59 Studies Found
| Enrolling by invitation |
: Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE) : Alpha1-Antitrypsin Deficiency : 2016-08-12 : Biological: Alpha-1 MP Weekly intravenous infusions of 60 mg/kg Alpha-1 MP |
| Completed |
: Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency : Alpha 1-Antitrypsin Deficiency : 2005-09-08 : Drug: Aerosolized, Recombinant Alpha 1-Antitrypsin |
| Completed |
: A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency : Alpha₁-Antitrypsin Deficiency : 2014-10-31 :
|
| Completed |
: Genomic Research in Alpha-1 Antitrypsin Deficiency :
|
| Recruiting |
: Liver Disease in Patients With alpha1-antitrypsin Deficiency : alpha1-antitrypsin Deficiency : 2016-10-06 : Other: No intervention No Intervention, observational |
| Recruiting |
: Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency : Hereditary Emphysema (Alpha 1-antitrypsin Deficiency) : 2011-05-16 : Device: Implantation of intrabronchial valves (IBV) (Spiration IBV) In advanced emphysema due to alpha1 |
| Terminated |
: Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency : Alpha 1-Antitrypsin Deficiency : 2000-04-06 |
| Enrolling by invitation |
: Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency : Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency : 2016-06-03 : Biological: Alpha-1 MP Alpha-1 MP 60 mg/kg/week for up to 104 weeks |
| Completed |
: Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults : Alpha 1-Antitrypsin Deficiency : 2006-02-20 :
|
| Recruiting |
: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency :
: 2011-06-15 :
|